The Traderszone Network

Published in TZ Latest News 11 July, 2017 by The TZ Newswire Staff

Biotech company’s stock jumps 40% on promising drug to treat rare lung disease

Arena Pharmaceuticals’ drug Ralienpag met its Phase 2 program goals.